Package 71610-856-80

Brand: terazosin hydrochloride

Generic: terazosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71610-856-80
Digits Only 7161085680
Product NDC 71610-856
Product ID 71610-856_2314412e-c93d-5dfe-e063-6394a90ab8df
Description

180 CAPSULE in 1 BOTTLE (71610-856-80)

Marketing

Marketing Status
Marketed Since 2024-09-19
Brand terazosin hydrochloride
Generic terazosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Terazosin Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2314412e-c93d-5dfe-e063-6394a90ab8df", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217"], "spl_set_id": ["23142f45-f91f-e2e2-e063-6394a90a2f25"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "180 CAPSULE in 1 BOTTLE (71610-856-80)", "package_ndc": "71610-856-80", "marketing_start_date": "20240919"}], "brand_name": "Terazosin Hydrochloride", "product_id": "71610-856_2314412e-c93d-5dfe-e063-6394a90ab8df", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-856", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin Hydrochloride", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "2 mg/1"}], "application_number": "ANDA074823", "marketing_category": "ANDA", "marketing_start_date": "19980330", "listing_expiration_date": "20261231"}